Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (341-350 of 7,108) with videos related to

Pageof 711
Sort By:
Cancer Science|December 28, 2021
Nanomedicine targets iron metabolism for cancer therapyLiangru Lin, Hanqing Chen, Ruifang Zhao, et al.
Cancer Science|December 6, 2021
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumorsToshihiko Doi, Yasutoshi Kuboki, Yoichi Naito, et al.
Cancer Science|March 5, 2021
Histological sequence of the development of rat mesothelioma by MWCNT, with the involvement of apolipoproteinsMotoki Hojo, Yukio Yamamoto, Yoshimitsu Sakamoto, et al.
Cancer Science|October 22, 2022
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancerTakeshi Ishii, Yoshimitsu Akiyama, Shu Shimada, et al.
Cancer Science|November 7, 2022
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CMLTakaaki Ono, Naoto Takahashi, Masahiro Kizaki, et al.
Cancer Science|November 3, 2022
Correction
Cancer Science|September 9, 2022
Correction
Cancer Science|September 9, 2022
BRCA1 transports the DNA damage signal for CDDP-induced centrosome amplification through the centrosomal Aurora AHuicheng Qi, Megumi Kikuchi, Yuki Yoshino, et al.
Cancer Science|October 26, 2022
Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulationHiroki Komatsuda, Risa Wakisaka, Michihisa Kono, et al.
Cancer Science|October 26, 2022
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancerMasatoshi Yamazoe, Hiroaki Ozasa, Takahiro Tsuji, et al.
Pageof 711

Showing results (341-350 of 7,108) with videos related to

Sort By:
Pageof 711
Cancer Science|December 28, 2021
Nanomedicine targets iron metabolism for cancer therapyLiangru Lin, Hanqing Chen, Ruifang Zhao, et al.
Cancer Science|December 6, 2021
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumorsToshihiko Doi, Yasutoshi Kuboki, Yoichi Naito, et al.
Cancer Science|March 5, 2021
Histological sequence of the development of rat mesothelioma by MWCNT, with the involvement of apolipoproteinsMotoki Hojo, Yukio Yamamoto, Yoshimitsu Sakamoto, et al.
Cancer Science|October 22, 2022
Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancerTakeshi Ishii, Yoshimitsu Akiyama, Shu Shimada, et al.
Cancer Science|November 7, 2022
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CMLTakaaki Ono, Naoto Takahashi, Masahiro Kizaki, et al.
Cancer Science|November 3, 2022
Correction
Cancer Science|September 9, 2022
Correction
Cancer Science|September 9, 2022
BRCA1 transports the DNA damage signal for CDDP-induced centrosome amplification through the centrosomal Aurora AHuicheng Qi, Megumi Kikuchi, Yuki Yoshino, et al.
Cancer Science|October 26, 2022
Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulationHiroki Komatsuda, Risa Wakisaka, Michihisa Kono, et al.
Cancer Science|October 26, 2022
Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancerMasatoshi Yamazoe, Hiroaki Ozasa, Takahiro Tsuji, et al.
Pageof 711